There is an open reading frame in the E3 transcription unit of adenovirus type 3 (Ad3) and Ad7 that could encode a protein of 16 kDa (16K protein). Ad3 and Ad7 are members of subgroup B of human adenoviruses. Using a rabbit antipeptide antiserum, we show that the 16K protein is expressed in Ad3-and Ad7-infected cells at early and late stages of infection; it is not expressed in cells infected with an Ad7 mutant that deletes the 16K gene. The 16K protein was also transcribed and translated in vitro from DNA containing the open reading frame for the 16K protein. The 16K protein has two hydrophobic domains typical of integral membrane proteins; consistent with this, we detected 16K in the crude membrane but not the cytosol cellular fractions. Although 16K has two potential sites for Asn-linked glycosylation, the protein is not glycosylated. The 16K gene is located in the same position in region E3 as the gene for the 6.7K protein of subgroup C adenoviruses (Ad2 and Ad5). E3-6.7K is an Asn-linked integral membrane glycoprotein, localized in the endoplasmic reticulum, whose function is unknown. The 16K protein has a putative transmembrane domain located in the same place in 16K as is the transmembrane domain in 6.7K, and the C-terminal portion of 16K is partially homologous to the C-terminal cytoplasmic domain of 6.7K; we suggest that these domains in 16K and 6.7K may have a similar function. The N-terminal 102 residues in 16K are not found in 6.7K; these residues may have a function that is unique to the 16K protein. In common with all known E3 proteins, the 16K protein is dispensable for virus replication in cultured cells; this suggests that the 16K protein may function in virus-host interactions.
There are 49 human adenovirus serotypes (Ad1 to -49) classified into six subgroups (A to F) based on DNA genome homology, hemagglutination, neutralization, and oncogenicity in rodents (reviewed in reference 3). There is widely varying pathogenesis associated with infection by serotypes in different subgroups (41) . For example, subgroup C serotypes are the most common and cause acute upper and lower respiratory tract infections in infants and young children. Subgroup B and E serotypes infect adults as well as children and cause epidemics of acute respiratory disease. Subgroup C and some subgroup B serotypes can also form persistent infections; the virus can be shed for months to years, can be intermittent, and is asymptomatic. Subgroup D serotypes cause epidemic keratoconjunctivitis. The subgroup F viruses infect the gastrointestinal tract and cause infantile diarrhea. The molecular basis for this variation in pathogenesis by different adenovirus serotypes is unknown; however, differences in the way in which these viruses interact with the host immune system are probably one mechanism.
The ability of adenovirus to evade host immune surveillance must be crucial for the establishment of persistent infections. Differences in pathogenesis and ability to form persistent infections very likely depend on the presence or absence of certain adenovirus genes. Some of these genes will likely be in the E3 transcription unit, which is not required for virus replication in tissue culture but has several proteins that are believed to counteract host immune functions (reviewed in references 76 and 78 to 81). The 5Ј two-thirds of the E3 region, termed E3A (12) , is the most diverged part of the adenovirus genome (3, 10, 80) . Therefore, the identification and characterization of the E3 proteins will be necessary for understanding the mechanisms of persistence and pathogenesis of adenovirus. This information will also be important for the design of adenovirus vectors.
The functions of some of the E3 proteins ( Fig. 1 ) have been well characterized. The gp19K protein of Ad2 and Ad5 and its homologs in representative adenovirus serotypes from subgroups B through E (53) bind and retain major histocompatibility complex class I antigens in the endoplasmic reticulum (ER), thereby allowing infected cells to evade lysis by cytotoxic T lymphocytes (1, 2, 5-7, 15, 33, 34, 56) . The gp19K gene is lacking in subgroup A Ad12 (63) and subgroup F Ad40 (16), two serotypes that infect the gastrointestinal tract. However, Ad12 (59) and perhaps Ad40 (13) down-regulate class I antigen expression at the transcription level.
The E3 region of Ad2 and Ad5 also encodes a protein named 14.7K that protects adenovirus-infected cells from lysis by tumor necrosis factor (TNF) (22, 24, 40, 55) . The 14.7K protein also inhibits TNF-induced secretion of arachidonic acid (83) . TNF is a major inflammatory cytokine secreted by activated macrophages. Serotypes in subgroups A to E have a protein that is both serologically and functionally related to the subgroup C E3-14.7K protein (39) .
The Ad2 and Ad5 E3-10.4K and E3-14.5K proteins, which form a complex within membranes (37, 44, 45, 64) , protect infected cells from TNF lysis in the absence of the 14.7K protein (23) . This complex also down-regulates the epidermal growth factor receptor from the surface of infected cells (8, 35, 36, 68) . The 10.4K protein is implicated in down-regulation of the receptors for insulin and insulin-like growth factor 1 (46) ; the role of the 14.5K protein was not investigated. The 10.4K-14.5K complex may also inhibit translation of E1A mRNA (82) .
Studies of animals are consistent with a role for E3 proteins in adenovirus pathogenesis. In the cotton rat-lung model, deletion of the gp19K gene causes a marked increase in the lymphocyte and macrophage/monocyte response, whereas deletion of the E3B region encoding the 10.4K, 14.5K, and 14.7K proteins results in the infiltration of polymorphonuclear leukocytes (20) . These results are in accord with the proposal that the 10.4K, 14.5K, and 14.7K proteins block an early cytokine response and gp19K blocks a late T-cell response to virus infection (21) . In a vaccinia virus-mouse model, the 14.7K protein expressed from a vaccinia virus vector increases the virulence of the vector in immunocompetent mice (70) and in mice with severe combined immunodeficiency (71) . For unknown reasons, gp19K expressed from a vaccinia virus vector does not affect the virulence or T-cell response to the vector (14, 26) . There are several other proteins encoded by the E3 region of subgroup C serotypes; there are named 6.7K (74), 12.5K (28), and 11.6K (58, 67, 77) . The functions of these proteins are being studied.
The Ad2 E3-6.7K protein is an ER-localized integral membrane glycoprotein (73, 75) . There is an open reading frame (ORF) in the E3 region of Ad3, a subgroup B serotype, that is in a genomic location similar to that of the Ad2 6.7K gene (Fig.  1) ; this Ad3 E3 ORF could encode a protein with a molecular weight of 16,000 (16K protein) (61) . Ad7, another subgroup B serotype, has a highly related ORF (30) . The C-terminal region of the putative 16K protein has limited homology to that of the Ad2 and Ad5 6.7K protein (Fig. 2) (74) . In this study, we report that the 16K protein of Ad3 and Ad7 can be immunoprecipitated from infected cells. The 16K protein is a membrane protein that is synthesized at early and late stages of infection. Mutants that lack the gene for the 16K protein replicate as well as wild-type virus in cultured cells. Ad3 and Ad7 also express the E3-20.5K protein (Fig. 1) (29) , which localizes to membranes and is glycosylated (31) . These unique E3 proteins may account for some of the differences in disease manifestations between subgroup B and C adenoviruses.
MATERIALS AND METHODS

Cells and viruses.
Virus stocks were prepared in suspension cultures of human KB cells and were titered on human A549 cells as described previously (25) . The Ad3 E3 deletion mutant dl101 was obtained from V. Mautner (49) . The Ad7 E3 deletion mutants Ad7⌬10 and Ad7⌬11 were obtained from P. Hung (WyethAyerst Research).
Generation of antipeptide antiserum. Peptide P14-27 with the sequence (C) KTELRPSYGLPLLQ, corresponding to residues 14 to 27 in the predicted Ad3 16K protein, was purchased from Multiple Peptide Systems (San Diego, Calif.). The peptide was coupled to keyhole limpet hemocyanin, and rabbits were immunized with the peptide conjugate as described previously (66) . Antiserum to protein pVIII was prepared in rabbits against a TrpE-pVIII fusion protein expressed in Escherichia coli; details will be presented elsewhere.
Infections, protein labeling, immunoprecipitations, and SDS-PAGE. KB cells (10 7 cells) were infected with viruses at 20 PFU per cell, and proteins were labeled at early (7 to 11 h) or late (18 to 22 h) stages postinfection with 100 Ci of [ 35 S]Cys per ml (1,050 Ci/mmol; Dupont NEN Research Products, Boston, Mass.) in 1 ml of Cys-free minimal essential medium. In some experiments in which early proteins were labeled, the cycloheximide-enhanced procedure was used (77) ; this procedure did not alter the mobility of the 16K protein. Cells were lysed in 0.5 ml of Iso-Hi-pH buffer (0.14 M NaCl, 1 mM MgCl 2 , 10 mM Tris-HCl [pH 8.5]) containing 0.5% Nonidet P-40 and 1 mM phenylmethylsulfonyl fluoride, nuclei were removed by centrifugation, and the supernatant was subjected to immunoprecipitation with 5 to 10 l of antiserum and protein A-Sepharose (Sigma Chemical Co., St. Louis, Mo.) (69) . Immunoprecipitates were analyzed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) on 15 or 18% polyacrylamide gels as described elsewhere (29) .
Cell fractionation of (Fig. 2) . Residues 3 to 22 in the Ad3/7 16K protein are homologous to the N terminus of a 14K ORF in subgroup C (Fig. 2 ) and have very patchy homology elsewhere; this ORF does not contain an ATG, and there is no evidence that it is expressed in infected cells. The dashed line for subgroup C indicates the absence of the genes shown for subgroup B1. The question mark indicates that it is not known whether the Ad3/7 version of the Ad2/5 11.6K protein is expressed. The Ad3/7 20.5K protein has been shown to be expressed in cells (29, 31) ; the 20.5K protein is 34% identical in amino acid sequence to the putative 20.1K protein (61) . The Ad3/7 putative homolog of the Ad2/5 11.6K protein is quite divergent (38, 61) , so it is not clear whether this protein is expressed. The nucleotide numbering system used for the 16K gene in E3 of Ad3 (and for the deletion in H3dl101) is taken from the work of Signäs et al. (61) but modified so that the transcription initiation site, nucleotide ϩ1, is at the same site as in Ad2 and Ad5 (see reference 12). This is also true for the Ad7 16K gene and mutants (30) .
FIG. 2.
Predicted amino acid sequence of the 16K protein of Ad7 and Ad3. Dashes indicate that the amino acid is identical to that in Ad7. Potential transmembrane domains in the Ad3/7 16K protein are underlined twice. The two potential Asn-linked glycosylation sites are underlined; note that there is a Pro residue at position ϩ5 for each of these sites. The peptide used to generate the antiserum is shown in boldface. The Ad2/5 6.7K protein is shown for comparison. Small dots for the Ad2 6.7K protein indicate that the amino acids are absent. Note that there is significant homology between the 16K and 6.7K proteins in their putative transmembrane and C-terminal domains and that there is homology between residues 4 and 18 of 16K and a 14K ORF from Ad2 and Ad5. The C-terminal domain of the 6.7K protein is almost certainly cytoplasmic because the protein contains Asn-linked oligosaccharides near its N terminus (75) . Therefore, the C-terminal domain of the 16K protein is probably cytoplasmic.
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on June 20, 2017 by guest http://jvi.asm.org/ mM sucrose-10 mM Tris-HCl (pH 7.2)-1 mM phenylmethylsulfonyl fluoride, and lysed by douncing (loose-fitting Wheaton pestle B) until Ͻ5% of cells were intact. After removal of the nuclei, the sample was separated into cytosol and crude membrane fractions by centrifugation at 4ЊC in a microcentrifuge for 15 min at 13,000 rpm. The cytosol fraction and solubilized crude membrane nuclear fraction (the pellet) were subjected to immunoprecipitation followed by SDS-PAGE and fluorography.
In vitro transcription and translation of Ad7 16K. The gene for 16K was amplified by PCR from the Ad7 virus and cloned into the vector pSP64 Poly A (Promega, Madison, Wis.). The primers used were CCATTTACTGCATCTG TAACCACCCCGG and CGAAGTCTAGACATGGATCGTGAT. The vector was digested with SmaI and then incubated with Taq polymerase (1 U) and 2 mM dTTP. This treatment results in the addition of a thymidine residue at each of the 3Ј ends (48) . The PCR-amplified 16K gene was ligated into the T-tailed vector. Tunicamycin treatment. KB cells were infected as described except that tunicamycin, at a 10-g/ml final concentration, was added 1 h before and during the labeling period. Extracts were prepared, and the 16K protein was analyzed by immunoprecipitations and SDS-PAGE.
RESULTS
Immunoprecipitation of the 16K protein from KB cells infected with Ad3 or Ad7. Figure 2 shows the inferred amino acid sequence of the Ad3-Ad7 16K protein. A synthetic peptide representing residues 14 to 27 of the predicted protein was injected into rabbits, and the resulting antiserum was used to immunoprecipitate the [
35 S]Cys-labeled 16K protein from Ad3-or Ad7-infected cells. The immunoprecipitates were analyzed by SDS-PAGE. A single band that migrated at approximately 16 kDa was immunoprecipitated from both Ad3-and Ad7-infected cells (Fig. 3, lanes c and f) . The 16K protein was not obtained from infected cells with preimmune serum (lanes b and e) or from mock-infected cells with immune serum (lanes a and d) . Interestingly, even though 16K in Ad3 and that in Ad7 are nearly identical in sequence, the Ad3 version migrates slightly faster than the Ad7 version (compare lanes c and f).
The specificity of the P14-27 antiserum was further tested by the addition of the P14-24 synthetic peptide to the immunoprecipitation reaction as a competitive inhibitor. As shown in lane a of Fig. 4A , the peptide inhibited the immunoprecipitation of the 16K band from Ad3-infected cells. This result further indicates that the 16K band was specifically recognized by the P14-27 antiserum.
The 16K protein in Fig. 3 and 4A was labeled at early stages of infection. As shown in lane a of Fig. 4B , the 16K protein was also synthesized at late stages of infection (18 to 22 h postinfection) following the initiation of viral DNA replication. The immunoprecipitation of the precursor to virion protein VIII (lane b) confirms that the infection was in the late stage. There were no apparent differences in modification of 16K at early and late stages of infection.
Ad3 and Ad7 mutants with deletions in region E3 were used to further map the 16K gene; the sequences deleted are indicated in Fig. 1 . Cells were infected with Ad3, Ad7, or the mutants, and the 16K protein was immunoprecipitated from [ 35 S]Cys-labeled cell extracts. As predicted from the DNA sequence data, the 16K protein was immunoprecipitated from cells infected with Ad3, Ad7, Ad3dl101, and Ad7⌬10 but not from cells infected with Ad7⌬11 (Fig. 5) .
Altogether, these data indicate that the 16K protein immunoprecipitated by the P14-27 antiserum was expressed from the ORF at ATG-563 to TAG-1001 in region E3 of Ad3 and from the equivalent ORF in region E3 of Ad7.
The 16K protein is found in the membrane fraction. Hydropathy analysis (47) of the amino acid sequence of the 16K protein demonstrated that 16K has two hydrophobic regions (Fig. 2) . Therefore, we analyzed cells fractionated into cytosol and crude membrane fractions in order to determine whether the 16K protein is a membrane-associated protein. As predicted, the 16K protein from Ad3 and Ad7 was found exclusively in the membrane fraction (Fig. 6) . The 16K protein does not contain Asn-linked oligosaccharides. Considering that 16K is a membrane protein (Fig. 6) and that it has two potential sites for Asn-linked glycosylation (Fig.  2) , we asked whether 16K has Asn-linked oligosaccharides. Ad3-or Ad7-infected cells were labeled with [ 35 S]Cys in the presence of tunicamycin, a drug that prevents Asn-glycosylation (65) . Surprisingly, the mobility of the Ad3 and Ad7 16K was identical in the absence and presence of tunicamycin (Fig.  7) ; major histocompatibility complex class I antigens immuno- precipitated from the same extract were sensitive to tunicamycin (data not shown), indicating that the tunicamycin treatment was effective. We also found that the mobility of 16K on SDS-PAGE was not affected by digestion with endoglycosidase H or F and that 16K could not be labeled in vivo with [ 
H]mannose (data not shown). Thus, 16K is not Asn glycosylated.
The putative N-terminal signal sequence of the 16K protein is not cleaved. The sequence near the N terminus of 16K has features typical of signal sequences for membrane insertion, i.e., there is a positively charged residue (Lys) at the extreme N terminus and this is followed by a stretch of hydrophobic amino acids (Fig. 2) . To address whether this putative signal sequence is cleaved, Ad3-or Ad7-infected cells were labeled with [ 35 S]Met and 16K was immunoprecipitated; the only Met in 16K is the initiator (Fig. 2) , and so if 16K is labeled with (lanes e and f), indicating that whatever accounts for the differences in mobility between the Ad3 and Ad7 versions of 16K, it is not due to cleavage at the N terminus.
The Ad7 but not Ad3 16K protein may undergo posttranslational modification in vivo. To obtain further information on the mobility difference between Ad3 and Ad7 16K, the ORFs for both proteins were transcribed and translated in vitro and then immunoprecipitated and analyzed by SDS-PAGE. As shown in Fig. 8, lanes d, g, and i , the Ad3 and Ad7 16K proteins synthesized in vitro comigrated with each other and with the Ad3 16K protein synthesized in vivo. Thus, it appears that the Ad7 but not the Ad3 16K protein may undergo posttranslational modification in vivo such that its mobility is reduced on SDS-PAGE.
DISCUSSION
These data demonstrate that the ORF between ATG-563 and TAG-1001 in the E3 region of Ad3 and an equivalent ORF in the E3 region of Ad7 encode a 16K protein in infected cells. This protein was also immunoprecipitated after in vitro transcription and translation of the Ad7 16K gene. The 16K protein was not synthesized by a mutant that lacks the 16K gene. It was, however, synthesized by mutants that lack the E3 14.5K, 10.4K, putative 11.6K, 20.5K, putative 20.1K, and gp19K genes; thus, the products of these genes are not required for synthesis of the 16K protein.
The Ad3 and Ad7 16K proteins are 96.5% identical. Subgroup B adenoviruses have been divided into two DNA homology clusters, B1 and B2; Ad3 and Ad7 are members of B1, and Ad11 and Ad35 are members of B2 (50) . The predicted 34 C-terminal residues in 16K of Ad11 (50) and Ad35 (18) are highly related to those of Ad3 and Ad7 (not shown), strongly suggesting that the 16K protein is expressed in both the B1 and B2 clusters of subgroup B adenoviruses.
The 16K protein is in the same genomic location as the subgroup C adenovirus E3 6.7K protein (Fig. 1) , and the 6.7K and the 16K proteins have homology in the C terminus (Fig. 2) . This suggests that 6.7K and the C-terminal region of 16K may have a similar role during infection. The 6.7K protein is localized in the ER (75) ; the subcellular localization of 16K has not yet been determined inasmuch as our antiserum to 16K does The initiation codon for Ad3 16K is located 16 codons into the upstream 12.5K gene, and the stop codon is seven codons into the downstream gp19K gene (61) . In Ad2 and Ad5, there are gaps in the genome of 409 and 367 bp, respectively, between the 12.5K and 6.7K genes (12, 32) . This gap contains an ORF for a 14-kDa protein, although the ORF lacks an initiation codon (ATG) (Fig. 1) . For this ORF to be translated, the mRNA would need to have an initiation codon spliced to its 5Ј end; the only upstream ATG is ATG-291, the start codon for the 12.5K protein. Another possibility is that the potential protein from this ORF could initiate at a codon other than ATG. The potential protein encoded by this ORF has homology to the N-terminal portion of 16K (Fig. 2) and very patchy homology elsewhere. Therefore, it is conceivable that subgroup C adenoviruses do express a protein that is a functional equivalent of the N-terminal portion of 16K.
The 16K protein has two hydrophobic domains, one of 11 residues at positions 4 to 18 and another of 39 residues at positions 102 to 141 (Fig. 2) ; for ease of discussion, we will refer to these domains as H1 and H2, respectively. The presence of H1 and H2 suggests that 16K is an integral membrane protein. Consistent with this, 16K localized in the crude membrane and not the cytosol fraction of lysed cells.
There are two potential Asn-linked glycosylation sites in the 16K protein. However, it appears that these sites are not used because there was no shift in migration on SDS-PAGE when the protein was radiolabeled in the presence of tunicamycin, or when the protein was subjected to endoglycosidase H or F digestion. The minimum distance at which a glycosylated Asn residue is located relative to the hydrophobic domain, either N or C terminal, is 12 to 14 amino acids (51, 52) . If the region of 16K that contains the potential glycosylation sites is located in the lumen of the ER, the sites do conform to this rule and could, theoretically, be glycosylated. Perhaps more relevant is the observation that Asn-X-Ser/Thr sites are often not glycosylated (only about 50% frequency) when there is a Pro residue at position ϩ5, and to a lesser extent at ϩ7, relative to the Asn residue (19) . Also, peptides that have potential Asn-linked glycosylation sites with Pro at ϩ5 cannot be glycosylated in vitro (4, 57) . One potential glycosylation site in 16K has the sequence Asn-Ser-Thr-Leu-Pro-Ala-Pro, with Pro at ϩ5 and ϩ7, and the other site has the sequence Asn-Thr-Thr-Thr-Pro, with Pro at ϩ5 (Fig. 2) . The presence of Pro at ϩ5 at these sites may explain why they are not glycosylated.
The subgroup C 6.7K protein is a type III integral membrane Asn-linked glycoprotein, having a N exo C cyt orientation in the membrane (73, 75) . The orientation of the 16K protein has not been determined. The first hydrophobic domain, H1, could be a signal sequence for insertion into membranes; it has some features typical of signal sequences, i.e., a basic residue (Lys) near the N terminus followed by a central hydrophobic core of at least seven residues (Fig. 2) (62) . However, in contrast to most N-terminal signal sequences, the putative N-terminal signal sequence of the 16K protein is not cleaved because the protein retains the initiator Met. Perhaps the signal is not cleaved because of Pro-19 and Pro-24. Pro is usually absent from signal cleavage sites (54, 72) .
Given that H1 is an uncleaved signal sequence, it likely is a transmembrane domain (i.e., a signal-anchor sequence), with the N terminus on the lumenal side of the membrane. According to the helical hairpin model (17, 42) , Lys-2 should retain the N terminus in the cytoplasm, the hydrophobic domain would traverse the membrane, and the remainder of the protein would translocate into the cytoplasm. This orientation is also in accord with the rules for signal-anchor domains (27) , i.e., a net positive charge on the cytoplasmic side of the membrane. For H1, the charge is ϩ4 (ϩ2 for the N terminus and ϩ2 for Lys-2) on the N-terminal side of H1 and ϩ2 (ϩ2 for Lys-14, Ϫ2 for Glu-16, and ϩ2 for Arg-18) on the C-terminal side. The problem in proposing that H1 is a signal-anchor domain is that such domains usually form an ␣-helix and consist of about 20 residues (62), and the hydrophobic core of H1 is only 11 residues. However, H1 could exist as a random coil (62) , and Lys-14 and Glu-16 could neutralize each other within the membrane. Thus, we speculate that model A in Fig. 9 depicts the orientation of 16K in the membrane, i.e., the N terminus is in the cytoplasm, residues ca. 18 to 102 are in the lumen, residues ca. 103 to 137 span the membrane, and the C terminus is in the cytoplasm. This model would allow the portion of 16K that is related to the Ad2/5 6.7K protein (H2 and the C-terminal region [ Fig. 9D]) to have the same sequences in the membrane and the cytoplasm (75) . Figure 9 depicts other possible orientations of the 16K protein in the membrane. If H1 is not recognized as a signal sequence, then H2 could be the signal-anchor domain, resulting in a type III membrane protein with a N exo C cyt orientation (Fig. 9B) (60) . Another possibility is that the 38 amino acids of H2 could span the membrane twice (Fig. 9C) .
Although there are only four amino acid differences between the Ad3 and Ad7 16K proteins, the proteins did not comigrate on SDS-PAGE. Oddly, when the Ad7 16K protein was synthesized in vitro, it comigrated with the in vivo-synthesized Ad3 16K protein. This suggests that the Ad7 16K protein synthesized in vivo has undergone a modification that does not take PO 4 and 16K was immunoprecipitated, the 16K protein was not detected by SDS-PAGE (data not shown). This suggests that 16K is not phosphorylated. Therefore, the nature of the posttranslational modification on Ad7 16K is unknown.
As mentioned, the initiation codon for 16K is located 16 codons into the upstream 12.5K gene (61) . Since this is somewhat unusual, it is useful to speculate on how 16K may be expressed. Unfortunately, in contrast to the subgroup C adenoviruses (9, 11) , the structures of the E3 mRNAs for the subgroup B adenoviruses have not been published. Transcription probably initiates in the same place in a region that is highly homologous in subgroup B and C adenoviruses and is located 563 bp upstream of ATG-563 for 16K (61) . The 16K protein could be translated from an mRNA whose 3Ј splice site is located immediately upstream of ATG-563. Alternatively, 16K could be translated from the same mRNA as that for the putative 12.5K protein. There are only two ATGs in any reading frame upstream of ATG-563, one at nucleotide 289 which initiates 12.5K, and a second at nucleotide 296 in a different reading frame from 12.5K (61) . Both of these ATGs are predicted by the Kozak (43) rules to be inefficient. Thus, translation of 16K could occur by read-through of these upstream AUGs by the scanning ribosome.
